<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01543165</url>
  </required_header>
  <id_info>
    <org_study_id>B-1112/141-011</org_study_id>
    <nct_id>NCT01543165</nct_id>
  </id_info>
  <brief_title>Efficacy of Nefopam and Morphine in Balanced Analgesia for Acute Ureteric Colic</brief_title>
  <official_title>A Single Center, Prospective Randomized Double-blind Trial: Efficacy of Nefopam and Morphine in Balanced Analgesia for Acute Ureteric Colic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pharmbio Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <brief_summary>
    <textblock>
      This study is to see whether the combination regimen of ketorolac and nefopam is superior to
      that of ketorolac and morphine in controlling ureter stone-related acute flank pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The balanced analgesia regimen using both ketorolac and morphine is the most effective choice
      in controlling urolithiasis related acute pain. Previous animal and human studies reported
      that combination regimen of ketoprofen and nefopam showed synergistic effect in pain control.
      We hypothesized that using nefopam instead of morphine for ketorolac based combination
      analgesia will produce similar pain reduction without causing opioid-related side effect.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of pain reduction by visual analog pain scale</measure>
    <time_frame>At 30 and 60 minutes after primary study drug administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Additional analgesia requested by enrolled patients</measure>
    <time_frame>At 30 and 60 minutes after primary study drug administration</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">111</enrollment>
  <condition>Renal Colic</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sequential intravenous administration of ketorolac and nefopam</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sequential intravenous administration of ketorolac and morphine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intravenous administration of ketorolac</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac and nefopam balanced analgesia</intervention_name>
    <description>Sequential intravenous administration of ketorolac and nefopam</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Balanced analgesia using ketorolac and morphine</intervention_name>
    <description>Sequential intravenous administration of ketorolac and morphine</description>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pain control with single analgesics (ketorolac)</intervention_name>
    <description>This arm do not use balanced analgesia. Instead, ketorolac IV administration followed by 50cc normal saline administration (for blinding) will be used in this group.</description>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute flank with visual analog pain scale score equal or more than 5

          -  and most possible diagnosis after initial clinical exam is acute renal colic

        Exclusion Criteria:

          -  Pregnant or lactating women

          -  Patients whose use of any of the study drugs is contraindicated

          -  Patients with documented renal or hepatic failure or those with clinical findings
             suggesting the diagnoses

          -  Recent episode of acute myocardial infarction or patients with significant heart
             failure

          -  Patients with documented gastric/duodenal ulcer or those with clinical findings
             suggesting the diagnoses

          -  Patients with bleeding tendency

          -  Patients who have history of any seizure

          -  Patients with documented organic brain injury

          -  Patients taking warfarin

          -  Patients whose primary diagnosis is not renal colic
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kyuseok Kim, MD</last_name>
    <phone>82-31-787-3049</phone>
    <email>dremkks@snubh.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joonghee Kim, MD</last_name>
    <phone>82-10-9489-3696</phone>
    <email>joonghee@me.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Kyeongi-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyuseok Kim, MD</last_name>
      <phone>82-31-787-3049</phone>
      <email>dremkks@snubh.org</email>
    </contact>
    <contact_backup>
      <last_name>Joonghee Kim, MD</last_name>
      <phone>82-10-9489-3696</phone>
      <email>joonghee@me.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2012</study_first_submitted>
  <study_first_submitted_qc>March 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2012</study_first_posted>
  <last_update_submitted>December 13, 2012</last_update_submitted>
  <last_update_submitted_qc>December 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Renal colic</keyword>
  <keyword>Analgesia</keyword>
  <keyword>Nefopam</keyword>
  <keyword>Ketorolac</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colic</mesh_term>
    <mesh_term>Renal Colic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
    <mesh_term>Nefopam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

